Trulieve Announces Exclusive Partnership in Florida with Connected Cannabis & AlienLabs

1.3 min readPublished On: December 15th, 2022By

TALLAHASSEE, Fla. – Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF), announced their partnership with California-based Connected Cannabis and AlienLabs. As part of the announcement, Trulieve is the exclusive provider of Connected Branded products throughout Florida.

“Trulieve consistently seeks ways to introduce new products and better serve our patients,” said Kim Rivers, CEO of Trulieve. “Connected and AlienLabs represent a portfolio of top-shelf strains that have benefited medical patients in other states, and we’re now excited to exclusively offer these products exclusively in Florida.”

AlienLabs is well-known for its flower strains with a focus on top-shelf, exotic, indoor cannabis. As one of the first California cannabis brands, AlienLabs has established a reputation for pushing quality to new heights in cannabis and takes pride in creating new, unique strains with a menu where each strain is distinct. Two strains, Xeno and Kryptochronic, will be available at select Trulieve Florida locations beginning Dec. 15.

Connected Cannabis offers high-quality cannabis by developing different cultivation techniques to create the strains they are now best known for in the California market. Three strains, El Jefe, Gelonade, and Nightshade, will be available at select Trulieve Florida locations beginning Dec. 20.

As the state’s leading medical cannabis provider, Trulieve patients across Florida can choose from the largest selection of THC and CBD products available in a variety of consumption methods, including smokable flower, concentrates, edibles, capsules, syringes, tinctures, topical creams, vaporizers, and more.

(This information is primarily sourced from Trulieve Cannabis Corp.  Highly Capitalized has neither approved nor disapproved the contents of this news release. Read our Disclaimer here).

About the Author: HCN News Team

The News Team at Highly Capitalized are some of the most experienced writers in cannabis and psychedelics business & finance. We cover capital markets, finance, branding, marketing and everything important in between. Most of all, we follow the money.

Share This Story, Choose Your Platform!